SCHEMBL25544702

SCHEMBL25544702

N#Cc1ccc(-c2ccc(N(c3ccc4oc5ccccc5c4c3)c3ccc4oc5ccccc5c4c3)cc2)cc1C#N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 3/20 0.39
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
RAB9A P51151 2/20 0.38
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TNKS O95271 2/20 0.36
HTT P42858 2/20 0.35
LMNA P02545 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
THRB P10828 1/20 0.35
AHR P35869 2/20 0.35
PLA2G2A P14555 3/20 0.34
PLA2G4A P47712 3/20 0.34
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
CASP3 P42574 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23328492 1.00 ALDH1A1 (0.39) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL25544532 0.96 ALDH1A1 (0.40) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL23328471 0.96 ALDH1A1 (0.40) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL25543480 0.95 ALDH1A1 (0.39) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL25544696 0.90 ALOX5 (0.43) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL23328499 0.86 KDM4E (0.39) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL23328474 0.85 TNKS (0.50) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL14313931 0.85 TNKS (0.50) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL25544356 0.85 TNKS (0.50) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL23328695 0.85 ALDH1A1 (0.38) ALDH1A1KDM4ENPC1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-09-21 US disclosed
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-09-21 US disclosed
EP-4183784-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME Lapto Co., Ltd. (KR) 2023-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME SAT1, FTO, SETDB1 ALDH1A1 16/4885KDM4E 142/4885NPC1 2875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.